A recommendation by the government’s health advisers have said that women with invasive breast cancer could be injected with a magnetic marker liquid to tell doctors if their disease has spread.
The substance is called Magtrace, and has been shown to locate the presence of sentinel lymph nodes, which show if the cancer has progressed beyond the breast. NICE has issued draft guidance endorsing the use of Magtrace in conjunction with a probe called Sentimag.
![Het beste uit je content halen met een kloppend verhaal [10 stappen]](https://www.pharmamarketeer.nl/wp-content/uploads/2024/12/businesswoman-working-at-creative-office-2023-11-27-05-24-05-utc-1-80x60.jpg)
